MBRX Earnings

Quarterly EPS
$-945.00
Q3 2024
$-652.10
Q4 2024
$-316.00
Q1 2025
$-573.60
Q2 2025
$-340.00
Q3 2025
$137.24
Q4 2025
$-70.80
Q1 2026
$-28.00
Q2 2026
Latest RevenueN/A
Latest Net Income-7635000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$28.000-7635000—+95.1%
Q1 2026-$70.800-12845000—+77.6%
Q4 2025$137.24015.4M—+121.0%
Q3 2025-$340.000-25399000—+64.0%
Q2 2025-$573.600-17809000—+32.5%
Q1 2025-$316.000-5904000—+68.7%
Q4 2024-$652.100-6584000—+74.4%
Q3 2024-$945.000-7024000—+33.0%
Q2 2024-$850.000-4319000——
Q1 2024-$1,010.000-4970000——
Q4 2023-$2,542.800-10269000——
Q3 2023-$1,410.000-5609000——
Moleculin Biotech (MBRX) — Earnings